Cedars-Sinai Medical Center - Archive Autoimmunity, Immunology Research
Filter by year
2026
June
08,
2026
|
06:00 AM
America/Los_Angeles
The National Institutes of Health has launched its first agencywide Strategic Plan for Autoimmune Disease Research, a five-year initiative aimed at accelerating research into diseases that affect an estimated 50 million Americans and cost more than …
Read more
April
22,
2026
|
06:30 AM
America/Los_Angeles
For most of his life, Jake Raden was active and healthy. A successful asset manager with a blue-chip financial institution, Raden traveled the world and worked out regularly. Except for managing a genetic predisposition for high cholesterol, Raden …
Read more
2025
April
28,
2025
|
06:00 AM
America/Los_Angeles
Although rheumatoid arthritis is an autoimmune disease with no cure, a tailored, multidisciplinary treatment approach at Cedars-Sinai’s Inflammatory Arthritis Clinical Center helps patients get back to the activities they enjoy.“It may take trying …
Read more
2024
August
08,
2024
|
08:31 AM
America/Los_Angeles
Liver transplant is considered the best treatment for liver cancer, but only available for patients with early-stage disease. Now a study led by Cedars-Sinai Cancer investigators has concluded that immunotherapy could make liver transplant an option …
Read more
June
05,
2024
|
08:00 AM
America/Los_Angeles
A novel study, led by the Department of Biomedical Sciences at Cedars-Sinai and published today in the peer-reviewed journal Nature, shows how cells use a protein called PD-L1 to rally white blood cells to battle infections.The body’s immune system …
Read more
April
19,
2024
|
08:15 AM
America/Los_Angeles
Some soft tissue sarcomas, a rare type of cancerous tumor, are resistant to immunotherapy and chemotherapy treatment. But Cedars-Sinai Cancer investigators, in a study published in the peer-reviewed journal Nature Communications, have identified a …
Read more
April
17,
2024
|
11:00 AM
America/Los_Angeles
Using spatial analysis of tissue samples, Cedars-Sinai investigators have identified patterns that could predict whether patients with the most common type of ovarian cancer will experience early relapse after treatment. These patterns, detailed in …
Read more
February
27,
2024
|
08:00 AM
America/Los_Angeles
Two leading multiple sclerosis (MS) experts—Nancy Sicotte, MD, chair of the Department of Neurology and director of Multiple Sclerosis and Neuroimmunology at Cedars-Sinai, and Pascal Sati, PhD, director of the Neuro Imaging Program in the Department …
Read more
2023
August
28,
2023
|
06:30 AM
America/Los_Angeles
Two new publications from Cedars-Sinai neuroscientists are helping to advance scientific understanding of the complex molecular and cellular processes involved in Alzheimer’s disease—and the body’s innate immune mechanisms for fighting against the …
Read more
June
27,
2023
|
06:30 AM
America/Los_Angeles
Scleroderma is an autoimmune disease characterized by thickening and scarring of the skin and vital organs, and the narrowing of the blood vessels which lead to poor circulation. An estimated 100,000 people in the U.S. are living with …
Read more
June
21,
2023
|
08:00 AM
America/Los_Angeles
As men age, some of their cells lose the very thing that makes them biological males—the Y chromosome—and this loss hampers the body’s ability to fight cancer, according to new research from Cedars-Sinai Cancer.The study, published today in the …
Read more
June
16,
2023
|
11:00 AM
America/Los_Angeles
Cedars-Sinai investigators have identified several steps in a cellular process responsible for triggering one of the body’s important inflammatory responses. Their findings, published in the peer-reviewed journal Science Immunology, open up …
Read more
